TP53 and cervical carcinoma: The recombinant Tum 5-p53 fusion protein exhibited a good inhibitory effect on human hepatoma SMMC-7721 cells and human cervical cancer HeLa cells in vitro in a significantly dose-dependent manner (Additional file 1: Figure S10).